Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...
Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
10h
GlobalData on MSNDeFloria launches Phase II ASD irritability cannabis therapy trialThe Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
Why Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to Analysts
We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...
Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.
Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results